However, rates have so far declined or remained constant in the older age groups because of increasing medical treatment for benign urinary obstruction and resulting decrease in use of transurethral resection, which had previously led to many prostate cancer diagnoses (Evans and Møller, 2003): the future use of the PSA test will be critical. This evidence concerns the gene KLK3 and Familial prostate cancer.